Long-term follow-up of a randomized prospective trial comparing a standard 81mg dose of intravesical bacille calmette-guérin with a reduced dose of 27mg in superficial bladder cancer.
2003 ◽
Vol 21
(2)
◽
pp. 169-170
2002 ◽
Vol 89
(7)
◽
pp. 671-680
◽
1999 ◽
Vol 161
(5)
◽
pp. 1720-1720
◽
2006 ◽
Vol 175
(4S)
◽
pp. 268-269
◽
2017 ◽
Vol 225
(4)
◽
pp. S178
◽
1997 ◽
Vol 4
(2)
◽
pp. 139-143
◽
Keyword(s):
2006 ◽
Vol 5
(2)
◽
pp. 191
◽
Keyword(s):
2018 ◽
Vol 34
(12)
◽
pp. e3-e4